{"id":637522,"date":"2023-02-08T20:34:01","date_gmt":"2023-02-08T20:34:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=637522"},"modified":"2023-02-08T20:34:01","modified_gmt":"2023-02-08T20:34:01","slug":"the-acute-bacterial-skin-and-skin-structure-infections-market-to-grow-positively-at-a-significant-cagr-during-the-study-period-20192032-estimates-delveinsight","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/the-acute-bacterial-skin-and-skin-structure-infections-market-to-grow-positively-at-a-significant-cagr-during-the-study-period-20192032-estimates-delveinsight_637522.html","title":{"rendered":"The Acute Bacterial Skin and Skin Structure Infections Market to Grow Positively at a Significant CAGR During the Study Period (2019-2032), estimates DelveInsight"},"content":{"rendered":"
\"The<\/a><\/div>\n

DelveInsight’s “Acute Bacterial Skin and Skin Structure Infections Market Insight, Epidemiology and Market Forecast 2032<\/a>”<\/strong> report provides current treatment practices, emerging drugs, Acute Bacterial Skin and Skin Structure Infections market share of the individual therapies, current and forecasted Acute Bacterial Skin and Skin Structure Infections market size from 2019 to 2032 segmented by seven major markets. The report also offers current Acute Bacterial Skin and Skin Structure Infections therapy algorithms, market drivers, market barriers, and unmet medical needs to curate the best of the opportunities and assesses the underlying potential of the Acute Bacterial Skin and Skin Structure Infections market.<\/p>\n

 <\/p>\n

Acute Bacterial Skin and Skin Structure Infections Overview<\/strong><\/p>\n

ABSSSI is defined as a bacterial infection of skin with a lesion size area of ≥ 75 cm2<\/strong> (lesion size measured by the area of redness, edema or induration). ABSSSIs consist of the most frequently diagnosed skin infections worldwide.<\/p>\n

The symptoms observed in ABSSSI are extensive cellulitis, wound infection, major cutaneous abscesses, and burn infections. There are several pathogens that lead to ABSSSIs, such as Methicillin sensitive Staphylococcus aureus (MSSA), Methicillin resistant Staphylococcus aureus (MRSA), Beta-hemolytic Streptococcus, Escherichia coli, Enterococcus faecalis, Pseudomonas aeruginosa, and others.<\/p>\n

ABSSSIs may be either community-acquired or hospital-acquired, and the predisposing factors include trauma, chronic cutaneous lesions, preexisting skin conditions (e.g. tinea pedis), edema due to venous insufficiency, and immunosuppression. The most serious ABSSSIs which require hospitalization for parenteral antibiotic therapy are identified based on:<\/p>\n

(1) The nature of the potential causative pathogens (e.g. their virulence and resistance patterns) and <\/p>\n

(2) Host factors pointing to the severity of the disease.<\/p>\n

 <\/p>\n

Acute Bacterial Skin and Skin Structure Infections Epidemiological Insights<\/a><\/strong><\/p>\n

As per Delvelnsight’s analysis, the total acute bacterial skin and skin structure infections Incident cases in 2017 in 7MM were found to be approximately 7,259,000<\/strong>, out of which the highest incident cases of this disease were observed in the United States.<\/p>\n

 <\/p>\n

Acute Bacterial Skin and Skin Structure Infections Treatment Market <\/strong><\/p>\n

Management of an ABSSSI is based on a multidisciplinary approach. The first step of management of an ABSSSI is the evaluation of hemodynamic state. For hemodynamically unstable patients, resuscitation and appropriate antimicrobial coverage should begin immediately. Eradication of the causative organism, alleviation of signs and symptoms, avoidance of complications and preventing recurrences are the main goals of ABSSSI therapy. <\/p>\n

Treatment for ABSSSI usually includes an antimicrobial therapy, surgical drainage, and antibiotic therapy. The therapeutic approaches favored in treating skin infections include adjunctive therapies, early and appropriate empiric antibiotic therapy, wound culture with susceptibility testing and surgical drainage and debridement. Adjunctive therapies comprise daily dressing changes, use of topical solutions including non-specific antimicrobial drugs, hyperbaric oxygen treatments, debridement, and surgical interventions planned at the initiation of treatment.  <\/p>\n

 <\/p>\n

Promising Therapies in the Acute Bacterial Skin and Skin Structure Infections Pipeline<\/a><\/strong><\/p>\n